Fulgent Genetics vs Personalis
FLGT and PSNL side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FLGT and PSNL compare
Personalis is the larger company, worth 2.5 times as much as Fulgent Genetics ($1.7B against $679M).
Personalis grew revenue faster over the last twelve months (16.9% versus 4.7% for Fulgent Genetics).
Fulgent Genetics keeps more of each dollar of sales as profit, with a net margin of −27.5% compared with −148% at Personalis.
Fulgent Genetics scores higher on the StockData Score (8 against 5 for Personalis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FLGT | PSNL |
|---|---|---|
| Size and price | ||
| Market cap | $679M | $1.7B |
| Share price | $24.66 | $15.71 |
| Change, 1 year | −15.2% | 96.1% |
| Change, 5 years | −73.8% | 5.1% |
| Beta (5Y) | 0.89 | 1.87 |
| Employees | 1,300 | 260 |
| StockData Score | ||
| Total score | 8 (better) | 5 |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.1× (better) | 20.8× |
| P/B | 0.7× (better) | 7.9× |
| FCF yield | −0.21% (better) | −6.4% |
| Fair value | $46.08 | $3.28 |
| Margin of safety | 46.5% (better) | −379% |
| Growth | ||
| Revenue growth (TTM) | 4.7% | 16.9% (better) |
| Revenue growth, 5Y average | −5.2% | −2.4% (better) |
| Profitability | ||
| Gross margin | 33.8% (better) | 16.7% |
| Operating margin | −39.2% (better) | −157% |
| Net margin | −27.5% (better) | −148% |
| FCF margin | −0.42% (better) | −133% |
| Return on equity | −8.6% (better) | −62.1% |
| Return on invested capital | −12.0% (better) | −465% |
| Financial health | ||
| Debt / equity | 0.00 (better) | 0.00 |
| Interest coverage | −1307.9× | −684.0× (better) |
| Current ratio | 5.34 (better) | 4.53 |
| Altman Z-score | 5.18 | 8.83 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Buyback yield | 9.5% (better) | −8.0% |
| Shareholder yield | 9.5% (better) | −8.0% |
| Ownership | ||
| Held by institutions | 57.0% | 79.6% |
| Held by insiders | 39.5% | 15.0% |
| Insider net buying, 12 months | −$286K (better) | −$6.9M |
| Short interest, % of float | 12.1% | 7.4% |
Go deeper
- FLGT stock overview
- FLGT income statement
- FLGT valuation and score
- PSNL stock overview
- PSNL income statement
- PSNL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.